Rationale for a New Outpatient Drug Therapy Algorithm in COVID-19 Patients Based on the Principle of «Multi-hit» Approach

Author:

Zykov K. A.1ORCID,Sinitsyn E. A.1ORCID,Rvacheva A. V.2ORCID,Bogatyreva A. O.2,Zykova A. A.3,Shapovalenko T. V.4

Affiliation:

1. Pulmonology Research Institute; А. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

2. А. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

3. А. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation; JSC Medsi Group

4. JSC Medsi Group

Abstract

The aim of the work was to justify the algorithm of outpatient drug therapy in patients with COVID-19, based on the principle of «Multi-hit» Approach. The algorithm is based on the published results of clinical studies and observations, authors’ own practical experience in the use and management of more than 4 thousand patients diagnosed with COVID-19 of varying severity during the 2020 pandemic. The article substantiates a complex algorithm for the treatment of outpatients with COVID-19, which includes etiotropic, pathogenetic, and symptomatic components of therapy with different mechanisms of action. The described approach is the 1st stage (outpatient) of a complex algorithm for managing patients with COVID-19. It has been successfully implemented in the system of outpatient care for patients with novel coronavirus infections in several leading medical institutions in Russia. The authors believe that the developed algorithm for providing outpatient drug therapy for COVID-19, based on the principle of multiple exposure, may be useful in real clinical practice of managing patients with coronavirus infection.

Publisher

Publishing House OKI

Subject

Infectious Diseases,Microbiology (medical),General Medicine,Microbiology

Reference53 articles.

1. Otchet o tekushei situacii po bor’be s koronavirusom. Kommunikacionnii centr Pravitel’stva Rossiiskoi Federacii. 21.04.2021https://стопкоронавирус.рф (in Russian) ]

2. Temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection (COVID-19) of the Ministry of Health of the Russian Federation, version 10 (08.02.2021). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/662/original/Временные_МР_COVID-19_%28v.10%29.pdf (in Russian).)

3. Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X., Bucci E., Piacentini M., Ippolito G., Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020 May; 27 (5): 1451–1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23. PMID: 32205856; PMCID: PMC7091918.

4. Suhail S., Zajac J., Fossum C., Lowater H., McCracken C., Severson N., Laatsch B., Narkiewicz-Jodko A., Johnson B., Liebau J., Bhattacharyya S., Hati S. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. Protein J. 2020 Dec; 39 (6): 644–656. doi: 10.1007/s10930-020-09935-8. Epub 2020 Oct 26. PMID: 33106987; PMCID: PMC7587547.

5. Laforge M., Elbim C., Frère C., Hémadi M., Massaad C., Nuss P., Benoliel J.J., Becker C. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020 Sep; 20 (9): 515–516. doi: 10.1038/s41577-020-0407-1. Erratum in: Nat Rev Immunol. 2020 Aug 10;: PMID: 32728221; PMCID: PMC7388427.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3